Market Opportunities

THE WORKING GROUP


How space accelerates healthcare innovation.

Space offers unique conditions that can unlock new possibilities for pharma and biotech.

Microgravity enables experiments, models, and processes that are not achievable on Earth, opening high-value innovation pathways.

THE INNOVATION


Six pathways where orbital science compounds commercial returns.

Faster Biotech Innovation

Space becomes a new R&D layerthat accelerates discovery andvalidation cycles.

New answers to unmet medical needs

Microgravity enables advanced disease models and molecular insights for complex and chronic conditions.

Breakthrough potential for stagnant pipelines

Orbital environments reveal mechanisms and molecular behaviors impossible to observe on Earth.

Personalized & regenerative medicine

Organoids, stem cells, and 3D tissues grow differently in orbit, providing superior data for next-gen therapies.

Rapid mechanism-of-action validation

Space stresses biological systems in unique ways, helping confirm or challenge therapeutic hypotheses faster.

Longevity & prevention insights

Research on aging, muscle, bone, and immunity in space feeds directly into prevention and healthy-aging markets.

Join us today!

If you are a pharmaceutical or biotech company looking to understand how space can accelerate research, development, and innovation — this is the right place to begin.

The Working Group gives you simple, guided, and low-risk access to the world of microgravity and to the companies already developing advanced solutions in orbit.

Who's for

Pharmaceutical companies

Biotech and biopharma

R&D, Innovation, and BusinessDevelopment teams

Corporate Venture and TechnologyScouting units